What is 株式会社メディパルホールディングス buying in Japan next?
株式会社メディパルホールディングス (?) discloses its Japanese stakes under Japan’s own regime, EDINET large-shareholding reports (大量保有報告書), the side a US 13F is blind to. Japan is also the one market where a prediction is checkable almost immediately: the report is due within about five business days of crossing 5%, not the US 13F’s 45. Research, not investment advice.
Currently disclosed Japanese holdings
From 株式会社メディパルホールディングス’s latest EDINET 5% filings. Stake is the disclosed large-shareholding percentage.
| Issuer | Stake | Purpose | As of |
|---|---|---|---|
| 株式会社ＰＡＬＴＡＣ (8283) | 97.8% | activist | 2026-07-17 |
| ＪＣＲファーマ株式会社 (4552) | 22.5% | other | 2023-11-16 |
| クオールホールディングス株式会社 (3034) | 19.5% | strategic | 2023-11-17 |
| 日医工株式会社 (4541) | 9.8% | strategic | 2021-09-02 |
| 株式会社イーエムシステムズ （商号 株式会社ＥＭシステムズ） (4820) | 9.5% | strategic | 2023-11-16 |
The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.
The full Japan board, predicted and disclosed, is on Japan. How the model works and its honest limits are on methodology. Data as of 2026-07-17. Research, not investment advice, see the disclaimer.